Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PeptiDreamPPTDF -3.13%81 Days Sales Outstanding is 0.00 as of Jun. 2026. GuruFocus rates PPTDF with a GF Score™ of 81/100 and a GF Value™ of $5.83 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 839 Biotechnology companies, PeptiDream ranks worse than 67.7% on this metric.
PeptiDream (OTCPK:PPTDF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
PeptiDream Days Sales Outstanding Related Terms
PeptiDream Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for PeptiDream's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PPTDF vs VRTX, REGN, MRNA: Days Sales Outstanding Comparison
For the Biotechnology subindustry, PeptiDream's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PeptiDream Days Sales Outstanding vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PeptiDream's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where PeptiDream's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PeptiDream (PPTDF) has a Days Sales Outstanding of 0.00 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on PeptiDream and its competitors. Over the past decade, PeptiDream's Days Sales Outstanding has ranged from 40.09 to 153.53. According to the industry distribution chart, PeptiDream ranks #568 out of 839 companies in the Biotechnology industry, placing it in the top 67.7%.
Is PeptiDream's Days Sales Outstanding too high?
PeptiDream's current Days Sales Outstanding is 0.00. Over the past 10 years, this metric has ranged from a low of 40.09 to a high of 153.53. Based on the distribution chart, PeptiDream ranks #568 out of 839 companies in the Biotechnology industry, which is below the industry midpoint. Overall, PeptiDream has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PeptiDream's Days Sales Outstanding compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PeptiDream ranks #568 out of 839 companies for Days Sales Outstanding. This places PeptiDream in the lower half of its industry. The industry median Days Sales Outstanding is 68.64. Historically, PeptiDream's own Days Sales Outstanding has ranged from 40.09 to 153.53 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Biotechnology company?
The median Days Sales Outstanding among Biotechnology companies is 68.64, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on PeptiDream and its competitors. For the Biotechnology industry, the median Days Sales Outstanding is 68.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PeptiDream's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PeptiDream stock overvalued right now?
Based on GuruFocus' analysis, PeptiDream (PPTDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $5.83, compared to a current price of $6.98 — trading 19.6% above its estimated fair value. The current Days Sales Outstanding is 0.00. PeptiDream's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For PeptiDream (PPTDF), the current Days Sales Outstanding is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PeptiDream (PPTDF) Overvalued in 2026?
Based on GuruFocus' analysis, PeptiDream stock appears to be overvalued.
The current stock price of $6.98 is trading 19.6% above its estimated GF Value™ of $5.83.
GuruFocus considers PeptiDream to be Modestly Overvalued.
Key valuation signals for PPTDF:
Days Sales Outstanding: 0.00
GF Value™: $5.83 vs. price of $6.98 (19.6% above fair value)
No single metric tells the full story. See the PPTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
81GF Score
Get the complete analysis for PPTDF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PPTDF has been successfully added to your 
